The effect of vaginal erbium laser treatment for the genitourinary syndrome of menopause: A Randomized Controlled Study

Not Applicable

Completed

• Conditions: Genitourinary symptoms of menopausequality of lifevaginal health indexvaginal maturation indexvaginal microbiology; genitourinary symptoms of menopause; GSM; vulvovaginal atrophy; vaginal maturation index; vaginal health index

• Registration Number: TCTR20171025003
• Lead Sponsor: Faculty of medicine, Ramathibodi hospital, Mahidol university

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2017-10-24
• Study Start: 2017-10-25
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Female
• Target Recruitment: 34

Inclusion Criteria

1. Postmenopausal women including women with surgical menopause
2. Genitourinary symptoms of menopause affecting quality of life
3. Normal PAP smear
4. Willing to enrol the study

Exclusion Criteria

1. Genital ulcers an and any sexually transmitted disease within 30 days prior enrollment
2.Undiagnosed abnormal uterine bleeding
3. History of any forms of hormone replacement therapy within 3 months
4.photosensitivity
5. Genital prolapse stage 2 or more, according to POP-Q system

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Genitourinary symptoms 5 months Visual analog scale of each symptoms

Secondary Outcome Measures

Name	Time	Method
vaginal maturation index 5 months vaginal cytology and calculate base on intermediate epithelial cells and superficial cells,Vaginal health index 5 months clinical evaluation and scale by investigator,Vaginal microobiology 5 months Nugent scale,adverse events 5 months number and characteristics of adverse events during the study